|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03737 ZHONGZHIPHARM
Nominal 
0.970 +0.020 (+2.105%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 8.876% | 6.259% | 3.541% | 10.258% | 10.008% |
| ROAE (%) | 15.869% | 11.189% | 6.065% | 17.496% | 15.605% |
| Return on Capital Employed (%) | 13.748% | 9.300% | 5.094% | 14.815% | 13.362% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 59.427% | 58.726% | 60.775% | 61.800% | 62.189% |
| EBITDA Margin (%) | 15.150% | 12.580% | 8.577% | 16.346% | 16.040% |
| Pre-tax Profit Margin (%) | 10.127% | 7.155% | 3.539% | 10.426% | 11.618% |
| Net Profit Margin (%) | 7.941% | 5.826% | 2.985% | 8.637% | 8.545% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 1.436 X | 1.492 X | 1.712 X | 1.821 X | 1.986 X |
| Quick Ratio (X) | 0.894 X | 1.050 X | 1.177 X | 1.312 X | 1.515 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 41.241% | 46.357% | 40.873% | 42.151% | 40.386% |
| Total Debt / Total Assets (%) | 9.754% | 9.111% | 11.531% | 13.228% | 9.957% |
| Net Debt / Total Assets (%) | 0.585% | -11.206% | -3.782% | -7.471% | -19.744% |
| Total Debt / Shareholders' Funds (%) | 16.677% | 17.035% | 19.554% | 22.910% | 16.703% |
| Long Term Debt / Shareholders' Funds (%) | 9.468% | 9.434% | 8.971% | 8.927% | 8.379% |
| Net Debt / Shareholders' Funds (%) | 1.000% | -20.953% | -6.413% | -12.940% | -33.119% |
| Net Cash / (Debt) ($) | (10.489M) | 210.150M | 57.640M | 106.129M | 252.828M |
| Net Cash / (Debt) per share ($) | (0.012) | 0.243 | 0.067 | 0.126 | 0.301 |
| Total Debt / Capital Employed (%) | 14.768% | 14.935% | 17.174% | 20.095% | 14.854% |
| Interest Coverage Ratio (X) | 27.383 X | 20.932 X | 9.731 X | 33.047 X | 39.917 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 143.275 Day | 143.105 Day | 137.243 Day | 132.900 Day | 135.944 Day |
| Receivables Turnover (Day) | 56.941 Day | 60.481 Day | 60.257 Day | 59.835 Day | 55.041 Day |
| Payables Turnover (Day) | 33.899 Day | 31.045 Day | 24.166 Day | 24.434 Day | 25.796 Day |
| Remarks: | Real time quote last updated: 25/11/2024 14:14 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 83,440 |
| %Change | -38.147% |
| EPS / (LPS) | RMB 0.099 |
| NBV Per Share (¥) | RMB 1.282 |